Monday, September 14, 2026

SK Biopharmaceuticals Unveils Breakthrough Findings on NTSR1-Targeted Radiopharmaceutical SKL35501

SK Biopharmaceuticals will present findings on NTSR1-targeted treatments at the AACR Annual Meeting, showcasing innovative oncology research.

IAEA Chief Raises Concerns Over North Korea’s Nuclear Maneuvers

The IAEA has stated that operation signs continue to be observed at the experimental light water reactor in North Korea.

JLK Secures Brazil Regulatory Clearance as It Expands AI Imaging Push in Latin America

JLK accelerates its expansion into Brazil with AI medical imaging solutions, addressing rising healthcare demands for breast cancer and stroke.

Tag: R2P

No posts to display

Top News

- Our Sponsors Ad -

Follow us